The Association of American Cancer Institutes (AACI) has elected Dr. Gerold Bepler, president and CEO of the Barbara Ann Karmanos Cancer Institute in Detroit to serve a three-year term on the board of directors. Dr. Bepler has focused his career on researching risks, progression, treatments, and outcomes related to lung cancer and non-small cell lung cancer.
“I am honored and pleased to be elected to the AACI Board of Directors that represents elite cancer centers across the country,” says Dr. Bepler. “I look forward to collaborating with fellow board members to help cancer experts advance this nation’s cancer care.”
Bepler is the creator of the Karmanos Cancer Network, Michigan’s largest cancer care and research network. He has served as chair of the department of oncology at Wayne State University School of Medicine and is principal investigator of the NCI Comprehensive Cancer Center Support Grant. Additionally, Bepler is a member of the Women’s Choice Healthcare Advisory Board and was nominated to the Fleischner Society for Thoracic Imaging and Diagnosis.